Market Research Logo

Global Hospital-acquired Disease Testing Market 2015-2019

Global Hospital-acquired Disease Testing Market 2015-2019

About Hospital-acquired Diseases

Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and gastrointestinal illnesses. These infections appear between 48 hours and four days after a patient is admitted and are usually related to a treatment of procedure used to treat or diagnose the patient's initial illness or injury. Hospital-acquired diseases are preventable through adherence to strict guidelines and less usage of invasive equipment that must be followed by healthcare professionals while caring for the patient.

Technavio's analysts forecast the global hospital-acquired disease testing market to grow at a CAGR of 19.44% over the period 2014-2019.

Covered in this Report

In this report, Technavio covers the present scenario and the growth prospects of the global hospital-acquired disease testing market for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of testing products used in the following hospital-acquired disease infections: SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and others.

Technavio's report, Global Hospital-acquired Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hospital-acquired disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key Regions

  • Americas
  • APAC
  • EMEA
Key Vendors
  • Abbott Laboratories
  • Becton and Dickenson
  • bioMerieux
  • Roche Diagnostics
Other Prominent Vendor
  • Akers Biosciences
  • Alere
  • Beckman Coulter/Danaher
  • Cantel Medical
  • Cepheid
  • Diatherix Laboratories
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Gen-Probe
  • Humor Diagnostica
  • Life Technologies
  • Meridian Bioscience
  • Nordion
  • QIAGEN
Market Driver
  • Rising Prevalence of HAIs
  • For a full, detailed list, view our report
Market Challenge
  • Lack of Healthcare Infrastructure
  • For a full, detailed list, view our report
Market Trend
  • Technological Advancements
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Hospital Acquired Disease Testing Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Hospital Acquired Disease Testing Market: Abbott Laboratories Inc., Becton and Dickenson (BD), bioMerieux SA and Roche Diagnostics

Other Prominent Vendors in the market are: Akers Biosciences, Alere, Beckman Coulter/Danaher, Cantel Medical, Cepheid, Diatherix Laboratories, Eiken Chemical, Enzo Biochem, Fujirebio/Innogenetics, Gen-Probe, Humor Diagnostica, Life Technologies, Meridian Bioscience, Nordion and QIAGEN

Commenting on the report, an analyst from Technavio’s team said: “The technological advance in the molecular diagnostic field is one of the key trends in the global hospital acquired disease testing market. The continuous innovation in increasing the performance and speed of molecular diagnostics is an integral part of the infectious diagnostic testing field.”

According to the report, the rising prevalence of hospital acquired infections has a significant impact on both developed and developing countries and remains one of the major drivers of the growth of the market.

Further, the report states that lack of healthcare infrastructure, training, and awareness of how hospital acquired infections spread remain major hindrances to the growth of the market. Early diagnosis and regular monitoring of patients with these diseases is essential to identify, treat, and control their spread. This has generated substantial demand for hospital acquired disease testing products including instruments, testing kits, and reagents.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- http://www.technavio.com/report/hospital-acquired-disease-testing-market

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global Hospital Acquired Disease Testing Market 2014-2019 ($ millions)
    • Five Forces Analysis
  • Hospital Acquired Infections/Hospital Acquired Diseases
    • Background
      • Table Common HAIs in Acute Care Settings
      • Symptoms, Prevention, Testing, and Diagnosis of HAIs
    • Incidence and Prevalence of HAI
      • Developed Nations
        • Table Prevalence of HAI in Developed Nations
      • Low and Middle-income Nations
        • Table Prevalence of HAI in Low and Middle-Income Nations
        • Table Comparison of HAI in Developed and Low and Middle-income Nations
        • Table Hospital Acquired Infections in US (2011)
        • Table Estimated Treatment Cost and Mortality Associated with HAIs
  • Market Segmentation by Product
    • Table Segmentation of Global Hospital Acquired Disease Testing Market by Product 2014
    • Global UTI Testing Market
      • Market Size and Forecast
        • Table Global UTI Testing Market 2014-2019 ($ millions)
    • Global SSI Testing Market
      • Market Size and Forecast
        • Table Global SSI Testing Market 2014-2019 ($ millions)
    • Global Pneumococcal Infections Testing Market
      • Market Size and Forecast
        • Table Global Pneumococcal Infections Testing Market 2014-2019 ($ millions)
    • Global Bloodstream Infections Testing Market
      • Market Size and Forecast
        • Table Global Bloodstream Infections Testing Market 2014-2019 ($ millions)
    • Global MRSA Testing Market
      • Market Size and Forecast
        • Table Global MRSA Testing Market 2014-2019 ($ millions)
        • Table Global Hospital Acquired Disease Testing Market Segmentation Analysis 2014-2019
        • Table Segmentation of Global Hospital Acquired Disease Testing Market by Product Type 2014-2019
  • Geographical Segmentation
    • Table Global Hospital Acquired Disease Testing Market by Geographical Segmentation 2014
    • Hospital Acquired Disease Testing Market in Americas
      • Market Size and Forecast
        • Table Hospital Acquired Disease Testing Market in Americas 2014-2019 ($ millions)
    • Hospital Acquired Disease Testing Market in EMEA
      • Market Size and Forecast
        • Table Hospital Acquired Disease Testing Market in EMEA 2014-2019 ($ millions)
    • Hospital Acquired Disease Testing Market in APAC
      • Market Size and Forecast
        • Table Hospital Acquired Disease Testing Market in APAC 2014-2019 ($ millions)
        • Table Global Hospital Acquired Disease Testing Market Segmentation by Geography 2014-2019 ($ millions)
        • Table Global Hospital Acquired Disease Testing Market Segmentation by Geography (%)
  • Buying Criteria
  • Market Growth Drivers
    • Table Percentage of Elderly Aged above 65 in Different Regions 2012 and 2050
    • Table Estimated Percentage of Elderly Population 2012 and 2050
    • Table Immediate Control Measures for Management of HAIs
  • Drivers and their Impact
  • Market Challenges
    • Table Direct Costs and Prevalence of HAI in Europe and US
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • Abbott
        • Table Abbott Laboratories: Key Takeaways
      • BD
        • Table BD: Key Takeaways
      • bioMerieux
        • Table bioMerieux: Key Takeaways
      • Roche Diagnostics
        • Table Roche Diagnostics: Key Takeaways
    • Other Prominent Vendors
  • Key Vendor Analysis
    • Abbott Laboratories
      • Key Facts
      • Business Description
      • Business Segmentation
        • Table Abbott Laboratories: Business Segmentation
      • Business Strategy
      • Revenue by Business Segmentation
        • Table Abbott Laboratories: Revenue by Business Segmentation 2012
      • Revenue Comparison 2011 and 2012
        • Table Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 ($ millions)
      • Revenue by Geographical Segmentation
        • Table Abbott Laboratories: Revenue by Geographical Segmentation 2012
      • Key Information
      • SWOT Analysis
    • Becton, Dickinson and Co.
      • Key Facts
      • Business Description
      • Business Segmentation
        • Table Becton, Dickinson and Co.: Product Categorization
      • Revenue Segmentation by Business
        • Table Becton, Dickinson and Co.: Revenue Segmentation 2013
      • Segmental Revenue Comparison 2013 and 2012
        • Table Becton, Dickinson and Co.: Revenue Comparison ($ millions)
      • Revenue Segmentation by Geography
        • Table Becton, Dickinson and Co.: Geographical Segmentation 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • bioMeriux
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table bioMeriux: Business Segmentation by Revenue 2013
      • Geographical Segmentation by Revenue 2013
        • Table bioMeriux: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Roche Diagnostics
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table Roche Diagnostics: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
      • Geographical Segmentation by Revenue 2014
        • Table Roche Diagnostics: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report